[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Pharmdca [@Pharmdca](/creator/twitter/Pharmdca) on x 126.6K followers Created: 2022-04-04 13:25:10 UTC $CRVS Recent insider buying including CEO and CFO. CEO Dr. Richard Miller, founder of $PCYC ($21Billion acquisition) received 2020 Drug Hunter Award. CEO previous successes with Rituximab and Imbruvica. Possibility of partnership or deal in future for their anti-CD73 drug. XX engagements  **Related Topics** [acquisition](/topic/acquisition) [$21billion](/topic/$21billion) [$pcyc](/topic/$pcyc) [insider](/topic/insider) [$crvs](/topic/$crvs) [pharmdca](/topic/pharmdca) [Post Link](https://x.com/Pharmdca/status/1510971743476727815)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Pharmdca @Pharmdca on x 126.6K followers
Created: 2022-04-04 13:25:10 UTC
$CRVS Recent insider buying including CEO and CFO. CEO Dr. Richard Miller, founder of $PCYC ($21Billion acquisition) received 2020 Drug Hunter Award. CEO previous successes with Rituximab and Imbruvica. Possibility of partnership or deal in future for their anti-CD73 drug.
XX engagements
Related Topics acquisition $21billion $pcyc insider $crvs pharmdca
/post/tweet::1510971743476727815